Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome
In the original publication, part d of Figure 2 was mistakenly not included.
|
Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
The original article can be found online.
|
Introduction: Lynch syndrome—its molecular mechanism and current topics |
Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cellsAbstractBackground
Methotrexate (MTX) is used in first-line treatment of primary central nervous system lymphoma (PCNSL), but most cases result in relapse-acquired resistance to MTX. However, only few studies have reported on internal changes and chemotherapies in PCNSL.
Methods
In this study, we generated two MTX-resistant PCNSL cell lines, designated MTX-HKBML and MTX-TK, in addition to a MTX-resistant Burkitt lymphoma cell line, designated MTX-RAJI. We examined gene expression changes and drug sensitivity to a proteasome inhibitor, bortezomib, in these cells.
Results
Cytotoxic tests revealed that the 50% inhibitory concentration for MTX in MTX-HKBML is markedly higher than that in the other two cell lines. Expression of the genes in MTX and folate metabolisms, including gamma-glutamyl hydrolase and dihydrofolate reductase, are upregulated in both MTX-HKBML and MTX-TK, whereas the gene expression of folylpolyglutamate synthetase, thymidylate synthase, and methylenetetrahydrofolate dehydrogenase 1 were upregulated and downregulated in MTX-HKBML and MTX-TK, respectively, on the other hand, bortezomib sensitivity was observed in MTX-TK, as compared with control TK, but not in MTX-HKBML.
Conclusion
These results indicate the cell-type-specific changes downstream of metabolic pathways for MTX and folate, bortezomib sensitivity, and purine and pyrimidine syntheses, in each PCNSL cell line. The MTX-resistant lymphoma cell lines established may be useful for in vitro relapse models for MTX and development of salvage chemotherapy and drug discovery.
|
Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patientsAbstractBackground
The later-line treatment of metastatic renal cell carcinoma (mRCC) has been drastically changing by the development of immune-oncology drugs and molecular targeted treatment in recent years. Although the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model is useful for second-line setting, this model has the problem that over 50% patients are classified as intermediate risk group. The aim of this study is to evaluate whether the serum C-reactive protein (CRP) levels prior to second-line treatment could divide intermediate risk group patients.
Methods
We retrospectively reviewed 82 consequent intermediate-risk mRCC patients who received second-line molecular targeted therapy. We classified patients who had serum CRP higher than 0.5 mg/dl in elevated CRP group because the median baseline serum CRP level before second-line treatment was 0.51 mg/dl. We assessed the prognostic impact of serum CRP levels prior to second-line treatment initiation to predict overall survival (OS).
Results
Thirty-three out of 82 (40%) patients demonstrated elevated baseline CRP levels. The median OS of elevated and non-elevated CRP group was 11.5 (95% CI 5.4–17.5) and 29.4 (95% CI 25.5–33.5) months, respectively (p = 0.001). The serum CRP elevation could predict prognosis in intermediate risk patients treated with second-line treatment (HR 2.5, 95% CI 1.4–4.2, p = 0.001).
Conclusions
The serum CRP levels after first-line treatment termination could divide intermediate risk group mRCC patients into two prognostic subgroups in second-line targeted treatment setting.
|
Association of SNPs in the OBFC1 gene and laryngeal carcinoma in Chinese Han male populationAbstractBackground
Laryngeal carcinoma (LC) is one of common diagnosed head and neck malignancies. Telomere length has been reported involved in malignant transformation and tumorigenesis. We speculate that single nucleotide polymorphisms (SNPs) in telomere length-related gene oligonucleotide/oligosaccharide-binding folds containing 1 (OBFC1) may have an association with LC in Chinese Han male population.
Methods
To prove this hypothesis, we performed a case–control study to analyze the OBFC1 polymorphisms in 172 LC patients and 180 healthy controls. A total of five SNPs (i.e., rs9325507, rs3814220, rs12765878, rs11191865, rs9420707) were selected for further genotyping.
Results
There was a significant difference in rs9325507 T allele frequency (OR = 0.88, 95% CI 0.64–1.21, P = 0.036) and rs11191865 A allele frequency (OR = 0.86, 95% CI 0.62–1.18, P = 0.009) between patient and control groups. In addition, the rs9325507 T/C genotype, rs3814220 G/A genotype, rs12765878 C/T genotype and rs11191865 A/G genotype had a lower risk of LC based on the results of logistic regression model analysis.
Conclusions
The results indicate a potential association between OBFC1 and LC risk in Chinese Han male population. Further work is required to confirm these results and explore the mechanisms of these effects.
|
High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinomaAbstractBackground
In general, urine cytology is often problematic because of its low sensitivity, especially for low-grade urothelial carcinoma (UC) in clinical practice. To improve the sensitivity, we focused on 5-aminolevulinic acid (5-ALA), because recent studies suggested that 5-ALA-induced urine cytology can be used for photodynamic diagnosis. In this study, we evaluated the diagnostic efficacy of 5-ALA-induced fluorescent urine cytology for UC.
Methods
We included in this study 318 patients comprising 158 non-cancer patients, 84 bladder tumor patients, and 76 upper urinary tract urothelial carcinoma (UUT-UC) patients treated in our institution from March 2013 to September 2018. Using the same voided urine sample, we compared sensitivity and specificity between conventional urine cytology and 5-ALA-induced fluorescent urine cytology.
Results
Overall, the sensitivity of 5-ALA-induced fluorescent urine cytology was significantly higher than that of conventional urine cytology (86.9% vs. 69.4%; p = 0.0002), and the specificity was equivalently high (96.2% vs. 95.6%; p = 1.0). In subgroup analysis, the high sensitivity of 5-ALA-induced fluorescent urine cytology was also detected regardless of age, sex, and tumor type. However, in terms of stage and grade, differences were only detected in patients with less than pTa stage (89.2% vs. 52.1%; p = 0.0001) and low-grade tumor (91.5% vs. 51.1%; p < 0.0001).
Conclusions
5-ALA-induced fluorescent urine cytology was significantly more effective for UC diagnosis when compared with the conventional cytology, especially in patients with low-stage and low-grade tumors. These findings indicate that 5-ALA-induced fluorescent urine cytology may potentially be a very useful tool for clinical use.
|
Current clinical topics of Lynch syndromeAbstract
Lynch syndrome (LS) is one of the most common genetic cancer syndromes, occurring at a rate of 1 per 250–1000 in the general population. This autosomal dominant disease is caused by a germline variant in one of the four mismatch repair genes, MSH2, MLH1, MSH6, PMS2, or the EPCAM gene. LS develops at early ages in colorectal cancer (CRC), endometrial cancer, and various other associated tumors. Accurate diagnosis of LS and utilization of various risk-reduction strategies such as surveillance, prophylactic surgery, and chemoprevention could improve clinical outcomes. The efficacy of surveillance has only been proven for CRC; however, specialists have proposed surveillance for other LS associated tumors. Universal screening for tumor tissue using microsatellite instability testing or the mismatch repair protein immunochemistry in all CRC or endometrial cancers is recommended not only as a diagnostic tool for LS, but also as a predictive, prognostic, and therapeutic marker. Next-generation sequencing methods have revealed several conditions with phenotypes similar to LS, such as Lynch-like syndrome, constitutional mismatch repair deficiency syndrome, and polymerase proofreading-associated polyposis. Distinguishing LS from these similar conditions is clinically important, since clinical management for patients differs according to the conditions. Recently, immune checkpoint inhibitors have been shown to be a promising treatment against mismatch repair-deficient (dMMR) solid tumors. The efficacy of immune-checkpoint inhibitors in LS-associated tumors has been shown to be similar to that in sporadic dMMR tumors. This review discusses current clinical topics related to LS screening, diagnosis, surveillance, and therapy.
|
Genetic and genomic basis of the mismatch repair system involved in Lynch syndromeAbstract
Lynch syndrome is a cancer-predisposing syndrome inherited in an autosomal-dominant manner, wherein colon cancer and endometrial cancer develop frequently in the family, it results from a loss-of-function mutation in one of four different genes (MLH1, MSH2, MSH6, and PMS2) encoding mismatch repair proteins. Being located immediately upstream of the MSH2 gene, EPCAM abnormalities can affect MSH2 and cause Lynch syndrome. Mismatch repair proteins are involved in repairing of incorrect pairing (point mutations and deletion/insertion of simple repetitive sequences, so-called microsatellites) that can arise during DNA replication. MSH2 forms heterodimers with MSH6 or MSH3 (MutSα, MutSβ, respectively) and is involved in mismatch-pair recognition and initiation of repair. MLH1 forms a complex with PMS2, and functions as an endonuclease. If the mismatch repair system is thoroughly working, genome integrity is maintained completely. Lynch syndrome is a state of mismatch repair deficiency due to a monoallelic abnormality of any mismatch repair genes. The phenotype indicating the mismatch repair deficiency can be frequently shown as a microsatellite instability in tumors. Children with germline biallelic mismatch repair gene abnormalities were reported to develop conditions such as gastrointestinal polyposis, colorectal cancer, brain cancer, leukemia, etc., and so on, demonstrating the need to respond with new concepts in genetic counseling. In promoting cancer genome medicine in a new era, such as by utilizing immune checkpoints, it is important to understand the genetic and genomic molecular background, including the status of mismatch repair deficiency.
|
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysisAbstractBackground
Head and neck squamous cell carcinoma (HNSCC) is the six leading cancer by incidence worldwide. The 5-year survival rate of HNSCC patients remains less than 65% due to lack of symptoms in the early stage. Hence, biomarkers which can improve detection of HNSCC should improve clinical outcome.
Methods
Gene expression profiles (GSE6631, GSE58911) and the Cancer Genome Atlas (TCGA) HNSCC data were used for integrated bioinformatics analysis; the differentially expressed genes (DEGs) were then subjected to functional and pathway enrichment analysis, protein–protein interaction (PPI) network construction. Subsequently, module analysis of the PPI network was performed and overall survival (OS) analysis of hub genes in subnetwork was studied. Finally, immunohistochemistry was used to verify the selected markers.
Results
A total of 52 up-regulated and 80 down-regulated DEGs were identified, which were mainly associated with ECM–receptor interaction and focal adhesion signaling pathways. Importantly, a set of prognostic signatures including SERPINE1, PLAU and ACTA1 were screened from DEGs, which could predict OS in HNSCC patients from TCGA cohort. Experiment of clinical samples further successfully validated that these three signature genes were aberrantly expressed in the oral epithelial dysplasia and HNSCC, and correlated with aggressiveness of HNSCC patients.
Conclusions
SERPINE1, PLAU and ACTA1 played important roles in regulating the initiation and progression of HNSCC, and could be identified as key biomarkers for precise diagnosis and prognosis of HNSCC, which will provide potential targets for clinical therapies.
|
ΩτοΡινοΛαρυγγολόγος Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,
Translate
Ετικέτες
Δευτέρα 12 Αυγούστου 2019
Αναρτήθηκε από
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
στις
11:07 μ.μ.
Ετικέτες
00302841026182,
00306932607174,
alsfakia@gmail.com,
Anapafseos 5 Agios Nikolaos 72100 Crete Greece,
Medicine by Alexandros G. Sfakianakis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Αρχειοθήκη ιστολογίου
-
►
2023
(278)
- ► Φεβρουαρίου (139)
- ► Ιανουαρίου (139)
-
►
2022
(1962)
- ► Δεκεμβρίου (107)
- ► Σεπτεμβρίου (158)
- ► Φεβρουαρίου (165)
- ► Ιανουαρίου (163)
-
►
2021
(3614)
- ► Δεκεμβρίου (152)
- ► Σεπτεμβρίου (271)
- ► Φεβρουαρίου (64)
- ► Ιανουαρίου (357)
-
►
2020
(3279)
- ► Δεκεμβρίου (396)
- ► Σεπτεμβρίου (157)
- ► Φεβρουαρίου (382)
- ► Ιανουαρίου (84)
-
▼
2019
(11718)
- ► Δεκεμβρίου (265)
- ► Σεπτεμβρίου (545)
-
▼
Αυγούστου
(750)
- Medicine by Alexandros G. Sfakianakis,Anapafseos 5...
- Inflammation
- Radiology
- Programmed chromosome fission and fusion enab...
- Distinct immunology of the placenta
- Topography of the central retinal artery rele...
- No ‘gay gene’: Massive study homes in on gen...
- American Journal of Primatology
- Dermatological and Epidemiological Profiles ...
- Reply to Dr. Suga and Dr. Takenoshita Abstr...
- Με αυτό τον τρόπο το παιδί δεν θα εκδηλώσει ...
- Legends of Allergy and Immunology: Donald Y....
- The use of aggregation-induced emission prob...
- Αυτό το παυσίπονο αυξάνει τον κίνδυνο υπογλυ...
- VASCULARITY TARGETED PERCUTANEOUS ETHANOL IN...
- Leucine depletion extends the lifespans of l...
- Trends in Mortality From Human Immunodeficien...
- Associations between cerebrovascular risk fa...
- Stem Cells in the Treatment of Disease New E...
- Head and Neck
- British Journal of Oral and Maxillofacial Sur...
- Cancer Science
- Clinical Anatomy
- Medicine by Alexandros G. Sfakianakis,Anapafseos 5...
- Nanomaterials, Vol. 9, Pages 1218: Fabrica...
- Medicina, Vol. 55, Pages 547: Total Serum ...
- International Journal of Environmental Resear...
- Arts, Vol. 8, Pages 111: The Persistence o...
- Arbuscular mycorrhiza and plant chromium toleran...
- Adenine decreases hypertrophic effects through i...
- Degradation of 17α-ethinylestradiol by Enterobac...
- Special issue on Intelligence Computation Evolut...
- A nonlinear state marginal price vector model fo...
- What's new in academic International medicine? T...
- Mādhyamikas Playing Bad Hands: The Case of Custo...
- Microporous scaffolds support assembly and diffe...
- The Gender Gap in Globalization and Well-Being A...
- Evaluation of a trap-and-transport program for a...
- Proceedings of the Royal Society B, Vol. 286, ...
- Nuclear Medicine and Molecular Imaging, FDG PET...
- Experimental DermatologyVolume 28, Issue 9Pages:...
- Understanding Connection Between Poverty, Child...
- Surveillance efficiency evaluation of air qualit...
- Opioid Prescribing Can Be Reduced in Oral and Ma...
- Exploring How Pediatric Residents Develop Adapti...
- Perceptions of Sexual Harassment in Oral and Max...
- Comparative Efficacy of 35% Glycolic Acid Peel A...
- The impact of a complex consulting process with ...
- Oropharyngeal recovery in a patient with the phar...
- Platelet-rich plasma protocols can potentiate vas...
- Relationship between Obesity and Balance in the ...
- Dabigatran for catastrophic antiphospholipid syn...
- Recovery of left ventricular twist and left vent...
- Don't Panic, Scientists Haven't Shown C-Section...
- USDA food safety leaders By Dan Flynn on Aug 29,...
- cGMP Signaling and Modulation in Heart FailureCy...
- SAGE Cardiology and Cardiovascular Medicine hu...
- A clinical comparative study of four interocclus...
- Global vascular guidelines on the management of ...
- Wound Repair and RegenerationEarly View Online...
- The ellipselet transformZahra Khodabandeh, Hosse...
- Public Health Law News Announcements...
- Determining the Association Between End-of-Life ...
- Incidence and risk factors of postoperative deli...
- Prognostic predictions based on pathological fin...
- Public Health Policies on E-Cigarettes Abstract ...
- Comparison of drug-eluting balloon with repeat d...
- What will surgical coronary revascularization lo...
- Anaesthetic considerations in nonagenarians and ...
- The statement of the Asia-Pacific Association fo...
- Duration of allergen immunotherapy for inhalant ...
- Transcranial Shear Wave Elastography of Neonatal...
- Effects of adjuvant mental practice using invers...
- Evidence-Based Use of Perioperative Antibiotic...
- Associations of awake and asleep blood pressure ...
- Diagnostic ‘nightmares’ in an HIV patient with a...
- Comparison of Commercial Enzyme-Linked Immunos...
- Archives of Disease in Childhood
- Segmental arterial mediolysis (SAM) is a nonathero...
- Cardiac MRI,
- Methods Used to Maximize Follow-up: Lessons Lear...
- Memories of Donald Dean Trunkey, Life-Saving Int...
- Building Blocks for Addressing Social Determin...
- Magnetic Resonance Imaging for the Follow-up of ...
- Pakistan Journal of Biological Sciences - Curre...
- Current Status and Future of Robotic Colorectal ...
- Daily Functioning in Schizophrenia: Is There Roo...
- Home-Based Cardiac Rehabilitation: A SCIENTIFIC...
- Obstructive Sleep Apnea and Primary Open-angle G...
- Correcting a Deficiency: Furthering Our Knowledg...
- Immunosuppression and Graft Rejection in Living-...
- American Journal of Orthodontics and Dentofacial O...
- The Pediatric Home Health Care Process: Perspe...
- ► Φεβρουαρίου (1143)
- ► Ιανουαρίου (744)
-
►
2017
(2)
- ► Φεβρουαρίου (1)
- ► Ιανουαρίου (1)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου